Overview of future innovative medicines and expected indication extensions.

Published on 

Oncology and Hematology

Abiraterone

Daratumumab

Dasatinib

Nivolumab

Pembrolizumab

Metabolism and Endocrinology

Chronic immune diseases

Infectious diseases

Lung diseases

Neurological disorders

Cardiovascular diseases

Older publications